AllianceBernstein’s LeMaitre Vascular LMAT Stock Holding History

AllianceBernstein’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.15M	Buy	26,524 +400	+2%	+$38.1K	﹤0.01%	1953
2025 Q4	$2.12M	Buy	26,124 +3,140	+14%	+$270K	﹤0.01%	1964
2025 Q3	$2.01M	Sell	22,984 -21	-0.1%	-$1.88K	﹤0.01%	1998
2025 Q2	$1.91M	Hold	23,005	–	–	﹤0.01%	1960
2025 Q1	$1.93M	Buy	23,005 +421	+2%	+$39.2K	﹤0.01%	1926
2024 Q4	$2.08M	Buy	22,584 +1,287	+6%	+$124K	﹤0.01%	1937
2024 Q3	$1.98M	Hold	21,297	–	–	﹤0.01%	1976
2024 Q2	$1.75M	Buy	21,297 +250	+1%	+$18.4K	﹤0.01%	2028
2024 Q1	$1.4M	Buy	21,047 +1,840	+10%	+$114K	﹤0.01%	2102
2023 Q4	$1.09M	Hold	19,207	–	–	﹤0.01%	2231
2023 Q3	$1.05M	Hold	19,207	–	–	﹤0.01%	2219
2023 Q2	$1.29M	Buy	19,207 +13	+0.1%	+$793	﹤0.01%	2144
2023 Q1	$988K	Sell	19,194 -2,270	-11%	-$110K	﹤0.01%	2233
2022 Q4	$988K	Buy	21,464 +21	+0.1%	+$983	﹤0.01%	2282
2022 Q3	$1.09M	Buy	21,443 +27	+0.1%	+$1.35K	﹤0.01%	2236
2022 Q2	$975K	Buy	21,416 +548	+3%	+$24.5K	﹤0.01%	2359
2022 Q1	$970K	Sell	20,868 -9,872	-32%	-$442K	﹤0.01%	2444
2021 Q4	$1.54M	Buy	30,740 +10,060	+49%	+$520K	﹤0.01%	2279
2021 Q3	$1.1M	Sell	20,680 -500	-2%	-$28.2K	﹤0.01%	2457
2021 Q2	$1.29M	Buy	21,180 +3,100	+17%	+$165K	﹤0.01%	2420
2021 Q1	$882K	Sell	18,080 -1,040	-5%	-$48.7K	﹤0.01%	2463
2020 Q4	$774K	Sell	19,120 -2,400	-11%	-$85.8K	﹤0.01%	2408
2020 Q3	$700K	Buy	21,520 +80	+0.4%	+$2.4K	﹤0.01%	2346
2020 Q2	$566K	Sell	21,440 -60	-0.3%	-$1.57K	﹤0.01%	2527
2020 Q1	$536K	Buy	21,500 +50	+0.2%	+$1.54K	﹤0.01%	2319
2019 Q4	$771K	Buy	21,450 +100	+0.5%	+$3.45K	﹤0.01%	2383
2019 Q3	$730K	Sell	21,350 -3,550	-14%	-$113K	﹤0.01%	2383
2019 Q2	$697K	Buy	24,900 +7,400	+42%	+$206K	﹤0.01%	2465
2019 Q1	$543K	Sell	17,500 -1,000	-5%	-$26.7K	﹤0.01%	2485
2018 Q4	$437K	Buy	18,500 +3,100	+20%	+$84.7K	﹤0.01%	2539
2018 Q3	$597K	Hold	15,400	–	–	﹤0.01%	2555
2018 Q2	$516K	Buy	15,400 +3,600	+31%	+$128K	﹤0.01%	2599
2018 Q1	$428K	Sell	11,800 -33,010	-74%	-$1.14M	﹤0.01%	2559
2017 Q4	$1.43M	Buy	44,810 +16,530	+58%	+$566K	﹤0.01%	2069
2017 Q3	$1.06M	Buy	28,280 +17,680	+167%	+$602K	﹤0.01%	2246
2017 Q2	$331K	Buy	+10,600	New	+$306K	﹤0.01%	2779

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AllianceBernstein's LMAT Position: Q1 2026 in Review

AllianceBernstein increased its LeMaitre Vascular (LMAT) stake by 1.5% in Q1 2026, buying an estimated $38.1K and bringing the position to 26,524 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

AllianceBernstein first reported a position in LMAT in Q2 2017 and has held it in 36 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

AllianceBernstein held 26,524 shares of LeMaitre Vascular worth $2.15M as of Q1 2026.
AllianceBernstein bought 400 LeMaitre Vascular shares in Q1 2026, an estimated $38.1K.
LeMaitre Vascular made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1953 holding.
AllianceBernstein first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 36 quarters since.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.